Simvastatin drug data and news

---

WHI analysis shows statin therapy not associated with breast ...  16 May 2006
Interestingly, the investigators did find that hydrophobic statins—a group that includes simvastatin, lovastatin, and fluvastatin—were associated with an 18 ... - TheHeart.Org,

Indian firms top DMF filing with US FDA  16 May 2006
For blockbuster molecules like Atorvastatin Calcium (brand name Lipitor with sales of $12 billion a year) and Simvastatin (brand name Zocor with 2005 sales of ... - Financial Express,

Ezetimibe + simvastatin as initial therapy in chronic kidney ...  May 11, 2006
The addition of ezetimibe to simvastatin as initial therapy for patients with chronic kidney disease was well tolerated and produced an additional 21% decrease ... - Therapeutics Daily (subscription) (press release),

Ranbaxy to launch Simvastatin in US  May 2, 2006
Country's leading drugmaker Ranbaxy Laboratories Ltd said on Tuesday that it will launch its Simvastatin drug after it gets the final nod from USFDA, whose ... - Hindustan Times,

Ranbaxy to launch Simvastatin in US after USFDA nod  May 2, 2006
New Delhi: Country's leading drugmaker Ranbaxy Laboratories Ltd today said it will launch its Simvastatin drug after it gets the final nod from USFDA, whose ... - NewKerala.com,

India's Aurobindo Pharma gets tentative FDA approval for ...  Apr 24, 2006
...(524804.BY) said Monday it has received a tentative approval from the US Food & Drug Administration for simvastatin, a medicine used to lower the level of ... - MarketWatch

Aurobindo gets tentative nod for Simvastatin  Apr 24, 2006
Aurobindo Pharma Ltd. announced on Monday that the USFDA has granted tentative approval for its Simvastatin Tablets USP 5 mg, 10 mg, 20 mg, 40 mg and 80 mg. ... - India Infoline.com,

Aurobindo Pharma receives US FDA approval for Simvastatin  Apr 24, 2006
Aurobindo Pharma Ltd has received US FDA tentative approval for the company`s Simvastatin Tablets USP 5 mg, 10 mg, 20 mg, 40 mg and 80 mg. ... - Myiris.com,

Aurobindo Pharma gets USFDA approval for Simvastatin  Apr 24, 2006
Mumbai: Aurobindo Pharma Ltd has received tentative approval from US FDA for its Simvastatin tablets used for treatment of high cholesterol. ... - NewKerala.com,

Pfizer:Analysis Shows Greater Benefits Of Lipitor Vs Zocor  May 15, 2006
...lipid lowering, trial to analyze the cost effectiveness of treatment with Lipitor and Zocor in Sweden, where Zocor is available generically as simvastatin. ... - Therapeutics Daily (subscription) (press release),

CRESTOR Helped More Patients Reach Goal in MERCURY II Study  May 15, 2006
II, which involved 1,993 high- and very high-risk patients, demonstrated that starting with or switching to CRESTOR from atorvastatin or simvastatin at the ... - Yahoo! News (press release)

Ranbaxy to launch Simvastatin in US after USFDA nod  May 2, 2006
New Delhi, May 02: Country's leading drugmaker Ranbaxy Laboratories Ltd today said it will launch its Simvastatin drug after it gets the final nod from USFDA ... - Zee News,

Aurobindo receives US FDA approval for Simvastatin.  Apr 25, 2006
Aurobindo Pharma is proud to announce that the US FDA has granted tentative approval for Aurobindo’s Simvastatin Tablets USP 5 mg, 10 mg, 20 mg, 40 mg and 80 ... - Moneycontrol.com (press release),

Aurobindo Pharma gets USFDA approval for Simvastatin  Apr 25, 2006
Mumbai, Apr 24 (PTI) Aurobindo Pharma Ltd has received tentative approval from US FDA for its Simvastatin tablets used for treatment of high cholesterol. ... - Therapeutics Daily (subscription) (press release),

Starting Statins Early During Acute Coronary Syndrome May Improve ...  May 15, 2006
...presentation with ACS. Three of the trials used atorvastatin, 1 used simvastatin, 4 used pravastatin and 1 used fluvastatin. In the ... - DG News

Clinical Data Announces Research Collaboration Agreement with Duke ...  May 15, 2006
...announced, the Clinical Data STRENGTH studies involved evaluating the response of 679 patients to atorvastatin, pravastatin, simvastatin, lovastatin and ... - PharmacoGenomicsOnline.com (press release),

Euphoria over cholesterol drug Zocor misplaced, say analysts  May 4, 2006
...the USFDA had unfairly denied Israeli drug company Teva's petition to exclusively market generic forms of Merck & Co's cholesterol drug Simvastatin sold under ... - Hindu Business Line,

Cholesterol-Lowering Statins Might Help Eyes  May 10, 2006
The Japanese study included 12 healthy men, average age 21 years, who received either a daily 20-milligram dose of the statin drug simvastatin (Zocor) or a ... - Forbes

Zocor ruling came as a surprise, say analysts  May 2, 2006
...informs that, last year both Ranbaxy and Teva had challenged US FDA’s decision on allowing Merck to withdraw their patents from orange book on Simvastatin. ... - Moneycontrol.com,

Ranbaxy, Reddy's vie for US cholesterol drug mart  May 2, 2006
Labs may soon be pitted against each other in a battle in the United States to capture the unlocked opportunity of cholesterol drug, Simvastatin, which goes ... - Rediff,

DRL, Ranbaxy, Teva to gain from Zocor ruling  May 5, 2006
US FDA falls in line with the recent court judgement, and reverses its original decision, Teva will get exclusivity on four strengths of Simvastatin (5mg, 10 mg ... - Economic Times,

Statins May Improve Circulation in the Retina  May 11, 2006
Asahikawa Medical College, Japan, and colleagues randomly assigned 12 healthy men (average age 21 years) to receive either a 20-mg dose of simvastatin or an ... - DG News

US court ruling favours Ranbaxy, Dr Reddy's  May 2, 2006
Ranbaxy may get a windfall by having six months without competition to sell generic versions of the widely prescribed Zocor (Simvastatin 80 mg). ... - Times of India,

Dr Reddy gains from Merck’s Zocor loss  May 2, 2006
Administration’s (FDA’s) denial of six-month marketing exclusivity to Israeli generics major Teva and Ranbaxy on the generic version (simvastatin) of Merck ... - Daily News & Analysis,

Pfizer's 2006 Lipitor sales target seen as difficult  May 8, 2006
...competition. And Pfizer is feeling the pain even before generic Zocor - which is known as simvastatin - hits the market next month. ... - MarketWatch

Statins may reduce eye-disease risk  May 9, 2006
Medical College in Japan and colleagues randomly assigned 12 healthy men (with an average age of 21) to receive either a 20-milligram dose of simvastatin or an ... - myDNA.com,

Zentiva NV 1st Quarter Results 2006  May 2, 2006
Amongst Zentiva’s top international promoted brands which have done well in Romania are the lipid lowering drug Simvacard (simvastatin), which ranked as the ... - PharmaLive.com (press release),

Ranbaxy, Dr Reddy's scrips surge after US court ruling  May 2, 2006
New Delhi: A day after a US district court ruled in favour of its first-to-file claim on cholestrol lowering drug Simvastatin, the generic version of Merck's ... - NewKerala.com,

Indian firms queue up for $20-bn US drug generics  May 7, 2006
In about two months from now, one of the largest selling drugs in the world Zocor (Simvastatin) will go off-patent, allowing companies to sell generic copies ... - Business Standard,

Express Scripts Granted 180-day Exclusivity For The Generic ...  May 1, 2006
...(ESRX | charts | news | PowerRating) announced that it has been granted a 180-day exclusivity for the generic version of Zocor, or Simvastatin. ... - Trading Markets,

US court tonic for drug duo  May 2, 2006
Mumbai, May 2: A US district court has ruled in favour of Ranbaxy Laboratories Ltd’s first-to-file claim on cholesterol lowering drug simvastatin, paving the ... - Calcutta Telegraph,

Statins May Improve Eye Circulation  May 8, 2006
19 and 23. The participants took either a 20-milligram dose of simvastatin or a placebo every day for seven days. Results reveal ... - Ivanhoe,

Sensex dips 77 points  Apr 24, 2006
The company has received US FDA tentative approval for the company`s Simvastatin Tablets Zocor, Merck`s brand name for Simvastatin, is the second largest brand ... - Myiris.com,

Dr. Reddy's shares jump on drug ruling  May 2, 2006
...patents expire. | Go to Sify Business Home page |. The patent on Zocor, or the generic simvastatin, expires on June 23. If the FDA ... - Sify,

Ranbaxy wins 180-day exclusivity for $4 bn drug  May 2, 2006
...are set to get 180-day exclusivity to market generic versions of Merck’s $4.38 billion anti-cholesterol drug Zocor (generic name simvastatin), when its ... - Financial Express,

Warning over grapefruit juice and cholesterol pills  May 10, 2006
The Medicines and Healthcare Products Regulatory Agency said the risk was greatest with Merck & Co Inc's Zocor, or simvastatin, which recently went on sale ... - Daily Mail - UK,

Are pills doing me any good?  Apr 23, 2006
QI HAVE been prescribed 10mg of simvastatin to control my cholesterol levels. ... A SIMVASTATIN is used to help with heart disease. ... - Therapeutics Daily (subscription) (press release),

Merck & Co: Treading the Biotech Path  May 10, 2006
...testing years ahead following the fall-out from the Vioxx (rofecoxib) withdrawal in 2004 and a crucial patent expiry to key drug Zocor (simvastatin) this year. ... - International News Service,

Kos Reports Continued Double Digit Increase in Revenue, Financial ...  May 9, 2006
...has now been completed in both pivotalPhase III trials intended to support the development of a new fixeddose combination of Niaspan with simvastatin, known as ... - Finanzen.net,

Business news in brief  May 12, 2006
About one in four doctors say they will make a generic version of Zocor, called simvastatin, their first choice when it becomes available, Gill said in a note ... - Philadelphia Inquirer,

Generic Pravachol Approved  May 10, 2006
...heart disease. Other drugs in this class include atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor). One other ... - Diabetes Self Management

Express Scripts Issues Statement On Generic Zocor Court Ruling ...  May 1, 2006
The company also commented on the court's decision granting 180-day exclusivity for the generic version of Zocor, or simvastatin. ... - Trading Markets,

Legal Wins Boost Drug Stocks  May 6, 2006
A federal court ruled that the US Food and Drug Administration's denial of a six-month exclusivity application for simvastatin, as Zocor is known generically ... - Forbes

Your health questions answered  May 9, 2006
A. The great majority of people who take statins (simvastatin, pravastatin, atorvastatin, and others) experience no side effects at all. ... - Independent,

Savings to Follow Generic Zocor Court Ruling  May 1, 2006
...(Nasdaq: ESRX - News) commented today on the court's decision granting 180-day exclusivity for the generic version of Zocor, or simvastatin. ... - Yahoo! News (press release)

Savings to Follow Generic Zocor Court Ruling,Express Scripts ...  May 2, 2006
...(NASDAQ:ESRX) commented today on the court's decision granting 180-day exclusivity for the generic version of Zocor, or simvastatin.During the 180-day ... - dBusinessNews St. Louis (press release),

Teva posts $1 billion Q1 loss on Ivax buy  May 11, 2006
...be awarded six months' marketing exclusivity for a copycat generic version of Merck's multi-billion dollar cholesterol-buster Zocor (simvastatin), which could ... - Pharma Times (subscription),